Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations
暂无分享,去创建一个
E. Alexeeva | T. Sleptsova | S. Valieva | R. Denisova | G. E | K. Isaeva | N. Taibulatov | Т. Bzarova | Chistyakova | А. М. Chomakhidze | А. N. Fetisova | М. S. Shingarova